FY 2022 Annual Performance Plan and Report - Regulatory Reform

Fiscal Year 2022
Released June, 2021

Topics on this page: Regulatory Reform

Regulatory Reform

On January 20, 2021, President Biden rescinded Executive Orders (EOs) 13771 Reducing Regulation and Controlling Regulatory Costs and EO 13777 Enforcing the Regulatory Reform Agenda from the previous administration. EO13771 required agencies to identify two deregulatory actions for every new significant regulatory action issued and EO 13777 directed agencies to establish a Regulatory Reform Task Force to review and evaluate existing regulations and to make recommendations for repeal or simplification.  HHS tracked progress on these two EOs through six measures until FY 2020.

Number of evaluations to identify potential EO 13771 deregulatory actions that included opportunities for public input and/or peer review (RR1)

Number of EO 13771 deregulatory actions recommended by the Regulatory Reform Task Force to the agency head, consistent with applicable law (RR2)

Number of EO 13771 deregulatory actions issued that address recommendations by the Regulatory Reform Task Force (final/published) (RR3)

Number of EO 13771 regulatory actions issued (final/published) (RR4a)

Number of EO 13771 deregulatory actions issued (final/published) (RR4b)

Total incremental cost of all EO 13771 regulatory actions and EO 13771 deregulatory actions (RR5)

⁵¹ Results have been updated since the FY 2021 Annual Performance Plan and Report released in March, 2020 to match the results published in the Federal Register.  Please reference Regulatory Reform under Executive Order 13771: Final Accounting for Fiscal Year 2018 - PDF and 2019 - PDF for more detailed information.